Dr. Hoffman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4755, Ogletown-Stanton Road
Newark, DE 19718
Education & Training
- University of Florida College of MedicineClass of 1991
Certifications & Licensure
- DE State Medical License 1995 - 2025
- PA State Medical License 1991 - 1996
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
Clinical Trials
- 17-OHPC in Pregnancy: IM vs SC Routes Start of enrollment: 2020 Jun 16
Roles: Contact
- DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational Diabetes Start of enrollment: 2024 Jul 01
Roles: Sub-Investigator, Contact
Publications & Presentations
PubMed
- Low-dose aspirin use in low-risk nulliparous pregnancies: a systematic review and meta-analysis of randomized controlled trials.Sascha Wodoslawsky, Kavisha Khanuja, Gabriele Saccone, Matthew K Hoffman, Vincenzo Berghella
American Journal of Obstetrics & Gynecology MFM. 2025-01-02 - Design and Conduct of Global Health Research in Low- and Middle-Income Countries.Sudhin Thayyil, Melissa Bauserman, Gregory Valentine, Jackie K Patterson, Matthew Hoffman
The Journal of Pediatrics. 2025-01-01 - A Validated Calculator to Estimate Risk of Chorioamnionitis in Laboring and Induced Patients at Term.Helen B Gomez Slagle, Richard Caplan, Tetsuya Kawakita, Anthony C Sciscione, Matthew K Hoffman
American Journal of Perinatology. 2024-10-08
Press Mentions
- Women Can Now Order a Blood Test to Predict Preterm BirthOctober 2nd, 2024
- Women Can Now Order a Blood Test to Predict Preterm BirthOctober 2nd, 2024
- Sera Prognostics PreTRM® Test Prevention Strategy Demonstrates 18% Reduction in Severe Neonatal Morbidity and Mortality in Newly Published AVERT TrialAugust 8th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: